Psoriasis Treatment Market Research Report - Forecast till 2032

Psoriasis Treatment Market Research Report Information By Drug Class (Tumor Necrosis Factor (TNF) Inhibitors {Adalimumab, Infliximab, Etanercept}, Anticholinergics {Ustekinumab, SecU.K.Inumab, Ixekizumab, Brodalumab}, Vitamin D Analogues {Calcitriol, Calcipotriol, Tacalcitol }), Treatment Type By Topicals ({Over-The-Counter (OTC) Topicals, Topical Non-Steroids, Topical Steroids}, Systemic {Retinoid, Cyclosporine, Methotrexate}, Biologics {Tumor Necrosis Factor Alpha (TNF-Α) Inhibitors, InterleU.K.In 12 And 23 (IL-12/23) Inhibitors, Interle

ID: MRFR/Pharma/2052-HCR | 90 Pages | Author: Kinjoll Dey | March 2024         

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL PSORIASIS TREATMENT MARKET, BY DRUG CLASS

6.1. Overview

6.2. Tumour Necrosis Factor Inhibitors

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.2.1. Adalimumab

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.2.2. Infliximab

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.2.3. Etanercept

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3. Anticholinergics

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.1. Ustekinumab

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.2. SecU.K.inumab

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.3. Ixekizumab

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.4. Brodalumab

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4. Vitamin D Analogues

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4.1. Calcitriol

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4.2. Calcipotriol

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4.3. Tacalcitol

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7. GLOBAL PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE

7.1. Overview

7.2. Topicals

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.2.1. Over-The-Counter (OTC) Topicals

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.2.2. Topical Non-Steroids

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.2.3. Topical Steroids

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3. Systemic

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3.1. Retinoid

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3.2. Cyclosporine

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3.3. Methotrexate

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4. Biologics

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4.1. Tumour Necrosis Factor Alpha (TNF-α) Inhibitors

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4.2. InterleU.K.in 12 and 23 (IL-12/23) Inhibitors

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4.3. InterleU.K.in 17 (IL-17) Inhibitor

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4.4. T Cell Inhibitor

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8. GLOBAL PSORIASIS TREATMENT MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Psoriasis Treatment Market

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Psoriasis Treatment Market

9.7. Key Developments and Growth Strategies

9.7.1. New Application Launch/Service Deployment

9.7.2. Mergers and Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix & Market Ratio

9.8.1. Sales & Operating Income 2020

9.8.2. Major Players R&D Expenditure 2020

9.9. Major Players Capital Market Ratio

10. COMPANY PROFILES

10.1. Novartis International AG

10.1.1. Company Overview

10.1.2. Application Type Overview

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. UCB

10.2.1. Company Overview

10.2.2. Application Type Overview

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. AstraZeneca

10.3.1. Company Overview

10.3.2. Application Type Overview

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Celgene Corporation.

10.4.1. Company Overview

10.4.2. Application Type Overview

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Johnson & Johnson

10.5.1. Company Overview

10.5.2. Application Type Overview

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Pfizer Inc

10.6.1. Company Overview

10.6.2. Application Type Overview

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Merck and Co. Inc

10.7.1. Company Overview

10.7.2. Application Type Overview

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. AbbVie

10.8.1. Company Overview

10.8.2. Application Type Overview

10.8.3. Financial Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Amgen.

10.9.1. Company Overview

10.9.2. Application Type Overview

10.9.3. Financial Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Others

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PSORIASIS TREATMENT MARKET SYNOPSIS, 2022-2030

TABLE 2 GLOBAL PSORIASIS TREATMENT MARKET ESTIMATES & FORECAST, 2022-2030 (USD MILLION)

TABLE 3 GLOBAL PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 4 GLOBAL PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 5 GLOBAL PSORIASIS TREATMENT MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 6 NORTH AMERICA: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 7 NORTH AMERICA: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 8 US: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 9 US: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 10 CANADA: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 11 CANADA: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 12 LATIN AMERICA: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 13 LATIN AMERICA: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 14 EUROPE: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 15 EUROPE: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 16 WESTERN EUROPE: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 17 WESTERN EUROPE: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 18 EASTERN EUROPE: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 19 EASTERN EUROPE: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 20 ASIA-PACIFIC: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 21 ASIA-PACIFIC: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: PSORIASIS TREATMENT MARKET, BY DRUG CLASS, 2022-2030 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCES

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL PSORIASIS TREATMENT MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL PSORIASIS TREATMENT MARKET

FIGURE 4 GLOBAL PSORIASIS TREATMENT MARKET SHARE, BY DRUG CLASS, 2020 (%)

FIGURE 5 GLOBAL PSORIASIS TREATMENT MARKET SHARE, BY TREATMENT TYPE, 2020 (%)

FIGURE 6 GLOBAL PSORIASIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: PSORIASIS TREATMENT MARKET SHARE BY REGION, 2020 (%)

FIGURE 7 NORTH AMERICA: PSORIASIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 8 EUROPE: PSORIASIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 WESTERN EUROPE: PSORIASIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 ASIA-PACIFIC: PSORIASIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 MIDDLE EAST & AFRICA: PSORIASIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 GLOBAL PSORIASIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 13 NOVARTIS INTERNATIONAL AG: KEY FINANCIALS

FIGURE 14 NOVARTIS INTERNATIONAL AG: SEGMENTAL REVENUE

FIGURE 15 NOVARTIS INTERNATIONAL AG: REGIONAL REVENUE

FIGURE 16 UCB

FIGURE 17 ASTRAZENECA

FIGURE 18 CELGENE CORPORATION

FIGURE 19 JOHNSON & JOHNSON

FIGURE 20 PFIZER INC

FIGURE 21 MERCK AND CO. INC

FIGURE 22 ABBVIE

FIGURE 23 AMGEN

FIGURE 24 ELI LILLY AND COMPANY

Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid

Research Methodology on Psoriasis Treatment Market


The systematic research methodology used in the preparation of this report on the psoriasis treatment market is divided into two main stages.


Primary Research:


Data obtained from primary sources is subjected to data triangulation methods with the help of tools such as structured questionnaires, interviews, surveys, and the combination of primary and secondary research sources. The main objective in this stage is to identify the opportunities, trends and challenges faced by the players operating in the psoriasis treatment market. It also helps to identify the important segments and regions in the market.


Secondary Research:


Secondary sources include company websites, press releases, industry magazines, published reports, and other trade journals. The objective of conducting this research is to analyze and obtain valuable insights about the industry that would be used for the development and economic analysis of the report.


Market Dynamics:


A combination of both qualitative and quantitative research is carried out to understand the various market dynamics such as drivers, challenges, opportunities, and trends in the psoriasis treatment market. These include:


• Market Drivers:


The escalating prevalence of psoriasis along with encouraging reimbursement policies and the rising adoption of biological drugs are the key factors driving the growth of the market.


• Market Restraints:


The high cost of treatment and certain side effects of psoriasis drugs restrict their adoption by the consumer.


• Market Opportunities:


The increasing emphasis on R&D activity by major players leading to an increase in the introduction of new drugs sustained growth in the geriatric population, and the growing focus on novel strategies like advancements in biologics are expected to present lucrative opportunities for the players operating in the market.


• Market Trends:


The growing focus of the industry players on drug patenting and drug pricing is the major trend in this market. Also, the expanding areas of application, such as the development of stents, injectables and wound care products, are likely to contribute to the growth of the global psoriasis treatment market.


Data Collection & Validation


The data is collected from primary and secondary sources and validated by various industry experts and stakeholders. Primary research includes in-depth interviews with executives, industry experts, and KOLs. Secondary research includes Factiva, Annual reports, industry magazines, marketing materials, relevant patent and regulatory databases, corporate presentations, and SEC filings.


Expert Panel Validation


The data gathered through primary research and secondary research is further validated by an expert panel. The panel consists of industry professionals and key opinion leaders in the market. The data is validated with the help of the panel’s discussions which involves the SWOT analysis and Porter’s Five Force Model.


Market Estimation & Forecasting


The data obtained from the primary and secondary sources is further analyzed and triangulated to arrive at the global market size of the psoriasis treatment market for the base year. The data collected and analyzed is further used to estimate the market size for different segments such as by product, by application, by region, etc. All the market size estimations obtained through these methods are further validated through primary interviews with key opinion leaders and executives in the industry.


Data Interpretation & Analysis


A detailed qualitative and quantitative analysis of the market is concluded to derive the market dynamics and their respective impact on the growth of the market. The impact of the political, economic, and social factors on the industry is studied. The data and information collected are further analyzed using tools such as Porter’s five forces model and SWOT analysis. This information is further used to derive the attractiveness of each segment and draw insights into the growth trends in the market.


The base year for the analysis is 2022 and a forecast period is created from 2023 to 2030. The forecast is derived after in-depth analysis and examination of historical data and market trends. The assumptions made for the forecast are those which are unavoidable for the client's purposes and are based on the industry’s knowledge.


Conclusion


The research report on the Psoriasis Treatment Market provides an unbiased view of the market by analyzing the various market segments along with their size, share, growth rate, trends, and potential opportunities in the market. The research report also provides a thorough analysis of the competitive landscape of the market and discusses the strategies adopted by the companies to gain a competitive advantage in the market. The report also provides market estimates and forecasts for the global psoriasis treatment market and its regional markets.

Speak to Analyst